Skip to main content
Veterinary Medicines

Noromox Prolongatum Vet. injektionsvæske, suspension 150 mg/ml

Authorised
  • Amoxicillin trihydrate
  • Amoxicillin trihydrate

Product identification

Medicine name:
Noromox Prolongatum Vet. injektionsvæske, suspension 150 mg/ml
Noromox Prolongatum Vet. 150 mg/ml injektionsvæske, suspension
Active substance:
  • Amoxicillin trihydrate
  • Amoxicillin trihydrate
Target species:
  • Cat
  • Cattle
  • Sheep
  • Pig
  • Dog
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    172.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • Amoxicillin trihydrate
    172.10
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
    • Cattle
    • Sheep
    • Pig
    • Dog
  • Intramuscular use
    • Sheep
    • Pig
    • Dog
    • Cat
    • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Scanvet Animal Health A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 13590
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, SUSPENSION 150 MG-ML)
Published on: 13/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."